Research Topics
| MICHAEL SCOTT SABELSummaryAffiliation: University of Michigan Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumorMichael S Sabel
University of Michigan, Department of Surgery, Division of Surgical Oncology, 3304 Cancer Center, 1500 East Medical Center, Ann Arbor, MI 48109 0932, USA
Cryobiology 53:360-6. 2006..Cryoablation prior to surgical resection of breast cancer can be used as a method to generate effector T-cells for adjuvant adoptive cellular immunotherapy...
Is duct excision still necessary for all cases of suspicious nipple discharge?Michael S Sabel
Departments of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Breast J 18:157-62. 2012..In selected patients with suspicious nipple discharge, but normal physical exam and diagnostic imaging, short-term observation with repeat evaluation seems reasonable for patients who do not desire duct excision...
Patterns of Internet use and impact on patients with melanomaMichael S Sabel
Department of Surgery, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, Michigan, USA
J Am Acad Dermatol 52:779-85. 2005..Our objective was to examine the use of the Internet and its impact among patients with melanoma...
The role of the surgeon in the management of melanomaM S Sabel
Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, 48109, USA
Minerva Chir 61:141-54. 2006..This article will review the evolution of melanoma surgery and the evidence behind today's recommendations...
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancerMichael S Sabel
Division of Surgical Oncology, University of Michigan, Ann Arbor, MI, USA
Breast Cancer Res Treat 122:325-36. 2010..The addition of IL-18 did not improve the efficacy...
Locoregional therapy of breast cancer: maximizing control, minimizing morbidityMichael S Sabel
University of Michigan Comprehensive Cancer Center, 3304 Cancer Center, Division of Surgical Oncology, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Expert Rev Anticancer Ther 6:1281-99. 2006..This article will review the importance of attaining optimum local control with minimum morbidity and examine where the future of locoregional therapy of breast cancer may lie...
Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cellsMichael S Sabel
Division of Surgical Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Surgery 142:749-60. 2007..The local and sustained release of IL-12 and TNF-alpha using PLAM synergistically activate both a cytotoxic T-cell and NK cell response, although their impact varies with MHC class I expression...
Generation of a tumor-specific systemic response after intratumoral injection of IL-12 and IL-18-loaded polylactic acid microspheresMichael S Sabel
Division of Surgical Oncology, University of Michigan, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109 0932, USA
J Immunother 30:808-16. 2007....
Sarcopenia as a prognostic factor among patients with stage III melanomaMichael S Sabel
Department of Surgery, University of Michigan, Ann Arbor, MI, USA
Ann Surg Oncol 18:3579-85. 2011..If the latter were true, then biologic frailty, and not age, should be an independent prognostic factor in melanoma...
Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responsesMichael S Sabel
Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Department of Surgery, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Cryobiology 58:1-11. 2009..This article reviews the existing evidence regarding tumor cryo-immunology and puts forward hypotheses regarding patient, tumor and technical factors that may influence the resultant immune response and warrant further investigation...
Residual disease after re-excision lumpectomy for close marginsMichael S Sabel
Division of Surgical Oncology, Department of Surgery, Biostatistics Core of the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
J Surg Oncol 99:99-103. 2009..We sought to examine the incidence of residual disease after re-excision for close margins and to identify predictive factors that may better select patients for re-excision...
Point: Interferon-alpha for adjuvant therapy for melanoma patientsMichael S Sabel
Department of Surgery, University of Michigan Comprehensive Cancer Center, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
J Natl Compr Canc Netw 2:61-8. 2004..Informed patients who have elected to forego interferon and patients with lower risk lesions can be offered participation in clinical trials with a no-treatment control arm...
Rate of freeze alters the immunologic response after cryoablation of breast cancerMichael S Sabel
Division of Surgical Oncology, University of Michigan, Ann Arbor, MI, USA
Ann Surg Oncol 17:1187-93. 2010..We sought to examine the impact that variances in technique might have on the immune response and examine the mechanism by which cryoablation may stimulate an antitumor immune response...
Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and consMichael S Sabel
Department of Surgery, University of Michigan Comprehensive Cancer Center, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Surg Oncol Clin N Am 19:519-38. 2010..This article addresses the clinical questions regarding the 2 approaches including the accuracy of the procedure and the prognostic information gleaned...
Surgical considerations in early-stage breast cancer: lessons learned and future directionsMichael S Sabel
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Semin Radiat Oncol 21:10-9. 2011..and intraoperative margin analysis. This article reviews several areas in which the surgeon can help ensure the success of breast-conservation therapy...
Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsyMichael S Sabel
Department of Surgery, University of Michigan Health System, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI, 48109 0932, USA
Ann Surg Oncol 19:287-93. 2012..We sought to validate recently published models meant to predict sentinel node status...
CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID miceMichael S Sabel
Department of Surgery, 3304 Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Cancer Immunol Immunother 54:944-52. 2005..These results sustain the notion that human anti-tumor immune response can be augmented (in vivo) by blocking the interaction between CTLA-4 and B7...
Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunityMichael S Sabel
Division of Surgical Oncology, University of Michigan, Ann Arbor, Michigan, USA
Ann Surg Oncol 11:147-56. 2004....
Pros and cons of adjuvant interferon in the treatment of melanomaMichael S Sabel
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
Oncologist 8:451-8. 2003..This manuscript reviews the leading arguments for and against its routine use and addresses questions regarding its role in the management of high-risk malignant melanoma...
Immunologic approaches to breast cancer treatmentMichael S Sabel
Department of Surgery, University of Michigan, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Surg Oncol Clin N Am 14:1-31, v. 2005..Obstacles to the clinical effectiveness of immunotherapies in breast cancer are also discussed...
Immunologic response to cryoablation of breast cancerMichael S Sabel
University of Michigan, 3304 Cancer Center, East Medical Center, 1500 East Medical Center, Ann Arbor, MI 48109 0932, USA
Breast Cancer Res Treat 90:97-104. 2005..To help define the mechanisms involved in the cryoimmunologic response, we compared cryosurgery to surgery in a murine model of breast cancer...
Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trialMichael S Sabel
Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Ann Surg Oncol 11:542-9. 2004..We conducted a multi-institutional pilot safety study of cryoablation in the treatment of primary breast carcinomas...
Sentinel node biopsy prior to neoadjuvant chemotherapyMichael S Sabel
Breast Oncology Program and Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Am J Surg 186:102-5. 2003..Sentinel lymph node biopsy prior to induction chemotherapy may address both...
Is there a role for adjuvant high-dose interferon-alpha-2b in the management of melanoma?Michael S Sabel
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
Drugs 63:1053-8. 2003..This article reviews the existing data and attempt to address the arguments for and against a role for adjuvant high-dose interferon-alpha-2b in the management of melanoma...
Tumor vaccines: a role in preventing recurrence in melanoma?Michael S Sabel
University of Michigan Comprehensive Cancer Center, Ann Arbor 48109, USA
Am J Clin Dermatol 3:609-16. 2002....
Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancerMichael S Sabel
Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, 3304 Cancer Center, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA
Am J Surg 187:673-8. 2004..Although sentinel lymph node biopsy (SNLB) has become a standard ancillary to breast conservation, there remains a hesitancy to perform SLNB concomitant with mastectomy primarily because of concerns regarding reoperation for a positive SLN...
Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated diseaseHank C Hill
Department of Surgery, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
Cancer Res 62:7254-63. 2002..These results establish that neoadjuvant in situ tumor immunotherapy with IL-12 + GM-CSF microspheres induces both innate and adaptive antitumor immune responses resulting in the eradication of disseminated disease...
Neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunityAlisha Arora
Division of Surgical Oncology, University of Michigan, Ann Arbor, Michigan 48109-0932, USA
J Surg Oncol 94:403-12. 2006..Neoadjuvant treatment was significantly superior to postoperative autologous cellular vaccines using IL-12 and TNF-alpha PLAM...
Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentationErika A Newman
Department of Surgery, The University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Ann Surg Oncol 14:2946-52. 2007..We report findings using a novel comprehensive approach to axillary management of node-positive-patients receiving neoadjuvant chemotherapy...
Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrenceKandice E Kilbride
Department of Surgical Oncology, University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA
Ann Surg Oncol 15:3252-8. 2008..The value of axillary staging prior to delivery of neoadjuvant chemotherapy (NEO) for breast cancer is controversial. Our goal was to analyze the prognostic and therapeutic impact of axillary staging on recurrence...
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph nodeAeisha K Rivers
Department of Surgery, St. Joseph's Hospital and Medical Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan, 48109, USA
Ann Surg Oncol 13:36-44. 2006..Patients with larger primary tumors, lymphovascular invasion, and extranodal extension are more likely to have ALND findings that will affect their cancer management...
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional studySandra L Wong
Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
Ann Surg Oncol 13:809-16. 2006..CONCLUSIONS: This study underscores the importance of ongoing prospective randomized trials in determining the therapeutic value of CLND after positive SLN biopsy in melanoma patients...
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsAmy C Degnim
Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
Cancer 98:2307-15. 2003....
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysisRohit Mehra
Department of Pathology, University of Michigan Medical School, Ann Arbor, 48109, USA
Cancer Res 65:11259-64. 2005..Our data suggest that immunohistochemical analysis of GATA3 may be the basis for a new clinically applicable test to predict tumor recurrence early in the progression of breast cancer...
Translational research in melanomaSusan Tsai
University of Michigan Comprehensive Cancer Center, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Surg Oncol Clin N Am 17:391-419, ix-x. 2008..With this in mind, there has been a fervent attempt to identify novel approaches to melanoma therapy and translate them into clinical use...
Melanoma: adjuvant therapy and other treatment optionsAlicia Terando
University of Michigan Comprehensive Cancer Center, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Curr Treat Options Oncol 4:187-99. 2003....
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanomaSandra C Paek
Department of Dermatology, University of Michigan Health System, Ann Arbor, Michigan, USA
Cancer 109:100-8. 2007..The objectives of the current study were to verify those previous results and to create a prediction model for the better selection of which patients with melanoma should undergo SLN biopsy...
Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?Timothy L Frankel
Department of Surgery, University of Michigan Health System, Ann Arbor, MI, USA
Ann Surg Oncol 15:2403-11. 2008..We examined whether the size and location of the metastases within the SLN may help further stratify the risk of additional positive NSLN...
Obesity and angiolymphatic invasion in primary breast cancerErin F Gillespie
University of Michigan Medical School, Ann Arbor, MI, USA
Ann Surg Oncol 17:752-9. 2010....
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapyErika A Newman
Department of Surgery, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan, 48109, USA
Ann Surg Oncol 13:52-7. 2006..001). CONCLUSIONS: Lymphatic mapping is feasible in patients undergoing mastectomy for LR and is likely to identify aberrantly located sentinel lymph nodes that would otherwise be overlooked with a conventional completion mastectomy...
Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanomaMichael S Sabel
Department of Surgery, University of Michigan Health System, Ann Arbor, MI 48109-0932, USA
J Am Coll Surg 201:37-47. 2005..Serial sectioning and immunohistochemistry on the NSLN in any "low-risk" group must be performed in a clinical trial to confirm that residual disease is unlikely before avoiding CLND can be recommended...
Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsyAmina Khan
Department of Surgery, Comprehensive Cancer Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan, 48109, USA
Ann Surg Oncol 12:697-704. 2005....
What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanomaHidde M Kroon
Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48105, USA
J Surg Oncol 95:623-8. 2007..However, this increases the number of SLN removed and the time and cost of the procedure. We examined the impact of raising this threshold on the accuracy of the procedure...
Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogramAmy C Degnim
Department of Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA
Am J Surg 190:543-50. 2005..The accurate prediction of nonsentinel node (NSN) metastasis in breast cancer patients remains uncertain...
Wide excision without radiation for desmoplastic melanomaAlisha Arora
Department of Surgery, University of Michigan, Ann Arbor, Michigan 48105, USA
Cancer 104:1462-7. 2005..This finding suggests that, for patients with desmoplastic melanoma, wide local excision with careful attention to appropriate margins produces excellent local control rates without the need for adjuvant radiation...
Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?Amy C Degnim
Division of Surgical Oncology, University of Michigan Health System, 1500 E Medical Center Drive, 3308 CGC Box 0932, Ann Arbor, Michigan, 48109, USA
Ann Surg Oncol 12:712-7. 2005..We hypothesized that blue dye could be safely omitted in the subgroup of patients who have evidence of successful sentinel node localization by lymphoscintigraphy...
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breastCelina G Kleer
Department of Pathology and Internal Medicine, University of Michigan, Ann Arbour, MI 48109 0054, USA
Breast Cancer Res Treat 93:101-10. 2005..We hypothesized that RhoC expression would identify aggressive, non-IBC tumors breast cancer patients at any stage with worse outcomes defined as recurrence and/or metastasis...
Prognostic significance of a positive nonsentinel lymph node in cutaneous melanomaAmir A Ghaferi
Department of Surgery, University of Michigan Health System, Ann Arbor, MI, USA
Ann Surg Oncol 16:2978-84. 2009..There may be additional prognostic significance to melanoma spreading from the SLN to nonsentinel lymph nodes (NSLN). We examined the implications of a positive NSLN for overall and distant disease-free survival...
Review of evidence-based support for pretreatment imaging in melanomaMichael S Sabel
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
J Natl Compr Canc Netw 7:281-9. 2009..This article reviews available literature on the role of pretreatment imaging in patients with newly diagnosed cutaneous melanoma...
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapyQuintin Pan
Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Health System, Ann Arbor, Michigan 48109, USA
Cancer Res 65:8366-71. 2005..Taken together, these results revealed that PKC epsilon plays a critical and causative role in promoting an aggressive metastatic breast cancer phenotype and as a target for anticancer therapy...
Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experienceMarilyn A Roubidoux
Department of Radiology, University of Michigan Comprehensive Cancer Center, 1500 E Medical Center Drive, Room 2910H, Ann Arbor, MI 48109-0326, USA
Radiology 233:857-67. 2004..Tumor size, mammographic density, and US characteristics may be indicators of likelihood of complete cryoablation...
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsCelina G Kleer
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
Proc Natl Acad Sci U S A 100:11606-11. 2003..This study provides compelling evidence for a functional link between dysregulated cellular memory, transcriptional repression, and neoplastic transformation...
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic modelVernon K Sondak
Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan, USA
Ann Surg Oncol 11:247-58. 2004..Several factors have been variably, and sometimes discordantly, reported to have predictive value for SLN metastasis to best select which patients require SLN biopsy...
The role of sentinel lymph node biopsy for melanoma: evidence assessmentTimothy M Johnson
Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA
J Am Acad Dermatol 54:19-27. 2006
Efficacy of sentinel lymph node biopsy in male breast cancerVincent M Cimmino
Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 0932, USA
J Surg Oncol 86:74-7. 2004..SLNB has been championed as a procedure aimed at preventing those morbidities. We recently have evaluated the role of SLNB in the treatment of men with early stage breast cancer...
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsyMichael S Sabel
Division of Surgical Oncology, Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Surgery 141:728-35. 2007..We sought to examine the effect this change has on the morbidity of the operation...
Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsyJonathan B McHugh
Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA
Ann Surg Oncol 13:1216-23. 2006..In our experience, drainage to multiple lymphatic basins was not an independent risk factor for sentinel lymph node metastasis and has no independent prognostic significance...
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancerRachel M Layman
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109 0848, USA
Clin Cancer Res 13:4092-7. 2007..We evaluated whether TP protein expression is increased by docetaxel and correlates with pathologic complete response (pCR) in breast cancer patients...
Surgical therapy of cutaneous melanomaDan G Blazer
Division of Surgical Oncology, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
Semin Oncol 34:270-80. 2007..This article will review the changes that have occurred leading to the current surgical approach to melanoma, the evidence behind these recommendations, and new questions that need to be addressed...
Efficient tumour formation by single human melanoma cellsElsa Quintana
Howard Hughes Medical Institute, Life Sciences Institute, Department of Internal Medicine, and Center for Stem Cell Biology, University of Michigan, Ann Arbor, Michigan 48109 2216, USA
Nature 456:593-8. 2008..Modifications to xenotransplantation assays can therefore dramatically increase the detectable frequency of tumorigenic cells, demonstrating that they are common in some human cancers...
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?Csaba Gajdos
Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan 48109 0932, USA
Cancer 115:5752-60. 2009..The authors examined the impact of SLN biopsy on prognosis and outcome in this patient population...
Is there a role for sentinel lymph node biopsy in the management of sarcoma?Dan G Blazer
Department of General Surgery, Division of Surgical Oncology, University of Michigan, 3304 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Surg Oncol 12:201-6. 2003..These include rhabdomyosarcoma, epithelioid sarcoma, clear cell sarcoma, synovial sarcoma, and vascular sarcomas. It is in these particular subtypes that there may be a benefit to SLN biopsy...
Does the method of biopsy affect the incidence of sentinel lymph node metastases?Erika L Newman
Department of Surgery, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, USA
Breast J 12:53-7. 2006..IHC should not be used routinely in the evaluation of the SLN and caution should be used when basing treatment decisions (completion axillary lymph node dissection or adjuvant therapy) on IHC-only detected micrometastases...
Sentinel lymph node biopsy for breast cancer: how many nodes are enough?Shaheen Zakaria
Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
J Surg Oncol 96:554-9. 2007..Sentinel lymph node (SLN) biopsy using blue dye and radioisotope often results in the removal of multiple SLNs. We sought to determine whether there is a point where the surgeon can terminate the procedure without sacrificing accuracy...
ADAM15 disintegrin is associated with aggressive prostate and breast cancer diseaseRainer Kuefer
Department of Urology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109 0944, USA
Neoplasia 8:319-29. 2006..These results suggest that ADAM15 is generally overexpressed in adenocarcinoma and is highly associated with metastatic progression of prostate and breast cancers...
Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer centerM Catherine Lee
Division of Surgical Oncology, The Department of Surgery and the Biostatistics Core of the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 0932, USA
Breast J 15:34-40. 2009..Examining BCT rates alone as a measure of quality, therefore, is not an appropriate standard across institutions serving diverse populations...
Research Grants
- Neoadjuvant Cytokine Immunotherapy by PLA MicrospheresMichael Sabel; Fiscal Year: 2007..I will pursue this area of investigation as a full-time faculty member, with full commitment from the Department of General Surgery and the Division of Surgical Oncology at the University of Michigan Medical Center. ..
